ArticleJournal of clinical microbiology2018
Multicenter Evaluation of the Modified Carbapenem Inactivation Method and the Carba NP for Detection of Carbapenemase-Producing Pseudomonas aeruginosa and Acinetobacter baumannii.
Open access · bronzeAbstract readComparative StudyEvaluation StudyMulticenter Study
In one paragraph
Article in Journal of clinical microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.
0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
43 citing papers in PubMed, 70 citations in OpenAlex.
- Comment on: An improved algorithm to screen for carbapenemase production inJAC-antimicrobial resistance · 2026Article
- Evaluation of Beta-Lactamase-Producing Strains Isolated in a Tertiary Nephrology Hospital in Romania.Antibiotics (Basel, Switzerland) · 2026Article
- The shift from "MIC-Only" back to carbapenemase testing among carbapenem-resistant Enterobacterales: what clinical laboratories need to know about updated CLSI guidance.Journal of clinical microbiology · 2026Review
- Review
- Differences in β-lactamase activity and carbapenem resistance among theAntimicrobial agents and chemotherapy · 2026Article
- Recent Advances and Future Perspectives in the Detection of Carbapenem-ResistantInfection and drug resistance · 2026Review
- Distribution of antimicrobial resistance genes and virulence genes in different genotypes of Acinetobacter baumannii.BMC infectious diseases · 2025Article
- Establishing Clinical and Laboratory Standards Institute M45 antimicrobial susceptibility testing methods and breakpoints forJournal of clinical microbiology · 2025Article
- In Vitro Activity of Novel β-Lactam/β-Lactamase Inhibitors Against Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2025Article
- Defining antimicrobial susceptibility testing methods and breakpoints amongJournal of clinical microbiology · 2025Article
- Variability of reagents matters-enhancements to the CLSI modified carbapenem inactivation method outside the United States to improve accuracy.Journal of clinical microbiology · 2025Article
- Comparison of six different methods used in detection of colistin resistance in extensively drug-resistant K. pneumoniae, A. baumannii and P. aeruginosa isolates with the reference method broth microdilution method.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025Article
- Laboratory detection of carbapenemases among Gram-negative organisms.Clinical microbiology reviews · 2024Review
- Evaluation of NG-Test CARBA 5 version 2, Cepheid Xpert Carba-R, and carbapenem inactivation methods in comparison to whole-genome sequencing for the identification of carbapenemases in non-fermenting Gram-negative bacilli.Journal of clinical microbiology · 2023Article
- Modelling interventions and contact networks to reduce the spread of carbapenem-resistant organisms between individuals in the ICU.The Journal of hospital infection · 2023Article
- The optimized carbapenem inactivation method for objective and accurate detection of carbapenemase-producingFrontiers in microbiology · 2023Article
- A Pooling Strategy for Detecting Carbapenem Resistance Genes by the Xpert Carba-R Test in Rectal Swab Specimens.Journal of clinical microbiology · 2022Article
- Carbapenemase-producingEmerging microbes & infections · 2022Review
- Phenotypic and genotypic detection methods for antimicrobial resistance in ESKAPE pathogens (Review).Experimental and therapeutic medicine · 2022Review
- Reply to Muntean et al. Comment on "Mitteregger et al. A Variant Carbapenem Inactivation Method (CIM) forPathogens (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 10 institutions in 1 country.
Patricia J SimnerDepartment of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA psimner1@jhmi.edu.
J Kristie JohnsonDepartment of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
William B BrassoBD Diagnostic Systems, Sparks, Maryland, USA.
Karen AndersonDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
David R LonswayDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Virginia M PierceDepartment of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
April M BobenchikDepartment of Pathology and Laboratory Medicine, Lifespan Academic Medical Center, Providence, Rhode Island, USA.
Zabrina C LockettBeckman Coulter Diagnostics, Inc., West Sacramento, California, USA.
Angella Charnot-KatsikasDepartment of Pathology, University of Chicago, Chicago, Illinois, USA.
Lars F WestbladeDepartment of Pathology, Weill Cornell Medicine, New York, New York, USA.
Brian B YooDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Stephen G JenkinsDepartment of Pathology, Weill Cornell Medicine, New York, New York, USA.
Brandi M LimbagoDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Sanchita DasDepartment of Pathology, NorthShore University HealthSystem, Evanston, Illinois, USA.
Darcie E Roe-CarpenterBeckman Coulter Diagnostics, Inc., West Sacramento, California, USA.
Centers for Disease Control and Prevention · USBeckman Coulter Foundation · USCornell University · USJohns Hopkins University · USMassachusetts General Hospital · USNorthShore University HealthSystem · USProvidence College · USUniversity of Chicago · USUniversity of Maryland, Baltimore · USWeill Cornell Medicine · US
Funding
Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1MNCATS NIH HHS UL1 TR001079
Abstract
The purpose of this study was to develop the modified carbapenem inactivation method (mCIM) for the detection of carbapenemase-producing
Indexed as
Acinetobacter baumanniiAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsDrug Resistance, MicrobialHumansMicrobial Sensitivity TestsPseudomonas aeruginosaSensitivity and SpecificityAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsAcinetobacter baumanniiCarba NPcarbapenemasecarbapenem resistancemCIMPseudomonas aeruginosa
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.